Physician profile
John D Hall
NPI 1912969304
$928.27
in general payments reported to CMS, 2019-2025
14 companies · $91.49 in 2025
The $91.49 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $124 · 2020: $48.26 · 2021: $148 · 2022: $168 · 2023: $210 · 2024: $138 · 2025: $91.49.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $440.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $439.78 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dexcom, INC. | $372.99 | 2021-2024 | Dexcom G6 Transmitter |
| Abbvie INC. | $105.63 | 2019-2025 | |
| Ascensia Diabetes Care US INC. | $97.80 | 2023-2024 | |
| Novo Nordisk INC | $89.36 | 2019-2024 | Wegovy |
| Medtronic, INC. | $60.22 | 2023-2024 | Minimed 780g |
| Tandem Diabetes Care, INC. | $36.98 | 2019 | |
| Amgen INC. | $32.61 | 2025 | Repatha, Otezla |
| Insulet Corporation | $27.80 | 2025 | Omnipod |
| Abbott Laboratories | $23.63 | 2022 | |
| Daiichi Sankyo INC. | $21.65 | 2023 | Injectafer |
| Janssen Pharmaceuticals, INC | $15.67 | 2021 | |
| Ibsa Pharma INC. | $15.59 | 2024 | Tirosint, Licart |
| Pfizer INC. | $15.12 | 2020 | |
| Allergan, INC. | $13.22 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Hall listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.